Addressing the Opioid Epidemic - Opportunities in the Postmarketing Setting

N Engl J Med. 2017 Apr 20;376(16):1502-1504. doi: 10.1056/NEJMp1614972.
No abstract available

MeSH terms

  • Analgesics, Opioid / therapeutic use
  • Direct-to-Consumer Advertising / legislation & jurisprudence*
  • Epidemics*
  • Government Regulation*
  • Humans
  • Opioid-Related Disorders / epidemiology*
  • Product Surveillance, Postmarketing*
  • United States / epidemiology
  • United States Food and Drug Administration

Substances

  • Analgesics, Opioid